Assessing global efforts to combat antimicrobial resistance

This article delves into the imperative task of understanding and evaluating global efforts to combat antimicrobial resistance, which poses a significant threat at national, regional, and global levels. National Action Plans (NAPs) stand as pivotal instruments guiding antimicrobial resistance governance within nations, yet a comprehensive analysis of these plans has been notably absent. Employing a meticulous governance framework, this study undertook a systematic review of publicly available NAPs from 114 countries, scrutinizing them across 18 domains and 54 indicators spanning policy design, implementation tools, and monitoring and evaluation. The research incorporated data from diverse sources and involved an exhaustive process of assessment, ranking, and analysis, revealing substantial variations in governance scores and highlighting key areas where improvements are needed to address this critical global health challenge effectively.¹

Read more here.

References

1. Patel, J., Harant, A., Fernandes, G., Mwamelo, A. J., Hein, W., Dekker, D., & Sridhar, D. (2023). Measuring the global response to antimicrobial resistance, 2020–21: a systematic governance analysis of 114 countries. Lancet Infectious Diseases, 23(6), 706–718. https://doi.org/10.1016/s1473-3099(22)00796-4

Disclaimers

• The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
• Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
• No official support by any organization(s) has been provided or should be inferred

Recommended Reads

• Highlighting Clinical Trials from the EMA
• The Ethics Behind Vaccine Trials, Policies, and Access
• COVID-19 Vaccinology: Evidence Generation, Learnings, and Implications
• Is There a Benefit to the Covid-19 Pandemic?
• News from the EMA